Clinical High Risk for Psychosis (CHR)
11
4
4
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
9%
1 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (11)
A Multimodal Imaging Study of Dopamine in Early Psychosis
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
Experience of UHR and PEP Individuals During Mindfulness: a Qualitative Phenomenological Study
Efficacy of Mindfulness in PREventing Progression to Psychosis in Individuals With an Ultra High Risk for Psychosis
Stratification and Treatment in Early Psychosis Study - PROMOTE
Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis
Mobile Thinking Intervention: A Inital Test
Interventions for Clinical High Risk Youth in Tunisia
Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic Communication
Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis
French Validation of Schizophrenia Proneness Instrument- Child Youth